Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

873 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Escherichia coli producing SHV-type extended-spectrum beta-lactamase is a significant cause of community-acquired infection.
Rodríguez-Baño J, Alcalá J, Cisneros JM, Grill F, Oliver A, Horcajada JP, Tórtola T, Mirelis B, Navarro G, Cuenca M, Esteve M, Peña C, Llanos AC, Cantón R, Pascual A. Rodríguez-Baño J, et al. Among authors: navarro g. J Antimicrob Chemother. 2009 Apr;63(4):781-4. doi: 10.1093/jac/dkp028. Epub 2009 Feb 17. J Antimicrob Chemother. 2009. PMID: 19223299
Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
Rodríguez-Baño J, Alcalá JC, Cisneros JM, Grill F, Oliver A, Horcajada JP, Tórtola T, Mirelis B, Navarro G, Cuenca M, Esteve M, Peña C, Llanos AC, Cantón R, Pascual A. Rodríguez-Baño J, et al. Among authors: navarro g. Arch Intern Med. 2008 Sep 22;168(17):1897-902. doi: 10.1001/archinte.168.17.1897. Arch Intern Med. 2008. PMID: 18809817
Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis.
Rodríguez-Baño J, Picón E, Gijón P, Hernández JR, Ruíz M, Peña C, Almela M, Almirante B, Grill F, Colomina J, Giménez M, Oliver A, Horcajada JP, Navarro G, Coloma A, Pascual A; Spanish Network for Research in Infectious Diseases (REIPI). Rodríguez-Baño J, et al. Among authors: navarro g. Clin Infect Dis. 2010 Jan 1;50(1):40-8. doi: 10.1086/649537. Clin Infect Dis. 2010. PMID: 19995215
Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli.
Rodríguez-Baño J, Picón E, Gijón P, Hernández JR, Cisneros JM, Peña C, Almela M, Almirante B, Grill F, Colomina J, Molinos S, Oliver A, Fernández-Mazarrasa C, Navarro G, Coloma A, López-Cerero L, Pascual A. Rodríguez-Baño J, et al. Among authors: navarro g. J Clin Microbiol. 2010 May;48(5):1726-31. doi: 10.1128/JCM.02353-09. Epub 2010 Feb 24. J Clin Microbiol. 2010. PMID: 20181897 Free PMC article.
Surveillance of transmitted drug resistance to integrase inhibitors in Spain: implications for clinical practice.
Alvarez M, Casas P, de Salazar A, Chueca N, Guerrero-Beltran C, Rodríguez C, Imaz A, Espinosa N, García-Bujalance S, Pérez-Elías MJ, García-Alvarez M, Iribarren JA, Santos J, Dalmau D, Aguilera A, Vinuesa D, Gutiérrez F, Piérola B, Molina JM, Peraire J, Portilla I, Gómez-Sirvent JL, Olalla J, Galera C, Blanco JR, Riera M, García-Fraile L, Navarro G, Curran A, Poveda E, García F; CoRIS. Alvarez M, et al. Among authors: navarro g. J Antimicrob Chemother. 2019 Jun 1;74(6):1693-1700. doi: 10.1093/jac/dkz067. J Antimicrob Chemother. 2019. PMID: 30838386
Immunosuppressed patients with pandemic influenza A 2009 (H1N1) virus infection.
Cordero E, Aydillo T, Fariñas MC, Paño-Pardo JR, Pachón J, Viasus D, Riera M, López-Medrano F, Payeras A, Moreno A, Rodríguez-Baño J, Oteo JA, Martínez-Montauti J, Torre-Cisneros J, Segura F, Carratalá J; Novel Influenza A(H1N1) Study Group of the SpanishNetwork for Research in Infectious Diseases (REIPI). Cordero E, et al. Eur J Clin Microbiol Infect Dis. 2012 Apr;31(4):547-56. doi: 10.1007/s10096-011-1346-3. Epub 2011 Jul 27. Eur J Clin Microbiol Infect Dis. 2012. PMID: 21792558 Free PMC article.
Score to identify the severity of adult patients with influenza A (H1N1) 2009 virus infection at hospital admission.
Capelastegui A, Quintana JM, Bilbao A, España PP, Garin O, Alonso J, Astray J, Cantón R, Castilla J, Castro A, Delgado-Rodríguez M, Godoy P, Gónzález-Candelas F, Martín V, Mayoral JM, Pumarola T, Tamames S, Soldevila N, Baricot M, Domínguez A; CIBERESP Cases and Controls in Pandemic Influenza Working Group, Spain. Capelastegui A, et al. Eur J Clin Microbiol Infect Dis. 2012 Oct;31(10):2693-701. doi: 10.1007/s10096-012-1616-8. Epub 2012 Apr 24. Eur J Clin Microbiol Infect Dis. 2012. PMID: 22526871 Free PMC article.
Impact of tenofovir on SARS-CoV-2 infection and severe outcomes among people living with HIV: a propensity score-matched study.
Nomah DK, Reyes-Urueña J, Díaz Y, Moreno S, Aceiton J, Bruguera A, Vivanco-Hidalgo RM, Casabona J, Domingo P, Navarro J, Imaz A, Deig E, Navarro G, Llibre JM, Miro JM; PISCIS study group. Nomah DK, et al. Among authors: navarro j, navarro g. J Antimicrob Chemother. 2022 Jul 28;77(8):2265-2273. doi: 10.1093/jac/dkac177. J Antimicrob Chemother. 2022. PMID: 35678461 Free PMC article.
873 results